Patents: The Real Stem Cell Fight

While “the scientists” have groused about the Bush policy as interfering with ESCR advances, the real hindrance in the field have been the patents claimed by the Wisconsin Alumni Research Foundation, based on James Thomson’s original work. As I wrote previously here and here, those patents are being challenged. Well, apparently round one goes to the Association. From the story:

The decision to uphold the 913 patent is the first in a review process that began in October 2006, when the patent office agreed to re-examine three UW-Madison stem cell patents following challenges brought by the New York-based Public Patent Foundation and the California-based Foundation for Taxpayer and Consumer Rights.

The two consumer organizations, which can appeal the decision to the Patent and Trademark Office’s Board of Patent Appeals once it is deemed final, have argued that the patents are overly broad and should never have been granted. They also contend that the patents have served to limit stem cell research in the United States.

They vowed to continue their patent challenge despite what they called “a non-final” decision by patent office regarding the inter partes re-examination of the 913 patent. WARF has 30 days to respond to the ruling, which is unlikely since it is a favorable one, and then the challenging parties would have 30 days to respond to WARF.

This fight over money illustrates a phenomenon that is too little understood in the country today: Science has become a commercial enterprise—even in the ivory covered walls of the university. The days of “publish or perish” are over. The current mantra is patent or perish.

Dear Reader,

Can I be direct with you?

War abroad. Socialists on the rise. AI upending human life. Endless uproar online. The modern attention economy doesn’t want readers — it wants users enslaved to the tyranny of the present.

First Things is the antidote: literary excellence, timeless truths, and a fixed point of reference in a culture that has lost its bearings.

But we can’t do it without readers like you.

Our goal: Raise $150,000 by November 1 to sustain First Things in the year ahead.


Your gift anchors readers in the permanent things.

Make your Fall Campaign gift now using the button below.

GIVE NOW

If you have any questions or would like more information, please contact Giovanni Del Piero, Director of the Editor’s Circle, at gdelpiero@firstthings.com or 212-627-1985.

Next
YOU MIGHT ALSO LIKE

The Church in the Age of Therapy

Matthew Loftus

In 1966, Philip Rieff wrote in The Triumph of the Therapeutic that “Religious man was born to…

Canada’s Deadliest Blind Spot

Anna Farrow

On September 20, the Daily Mail ran a story with the provocative headline, “Our 83-year-old Christian grandmother…

The Faithful Joy of Dolly Parton and Fulton Sheen

Mike Aquilina

Dolly Parton and Fulton Sheen seem to have had little in common. She favored rhinestones; he wore…